Home Newsletters Hepatic Cell News BH3-Only Protein Expression Determines Hepatocellular Carcinoma Response to Sorafenib-Based Treatment

BH3-Only Protein Expression Determines Hepatocellular Carcinoma Response to Sorafenib-Based Treatment

0
In the presence of NOXA, BIM-deficient hepatocellular carcinoma cells could be in turn strongly sensitized for cell death induction by the combination of sorafenib with TNF-related apoptosis-inducing ligand .
[Cell Death & Disease]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version